Metastatic Breast Cancer: CyberKnife for Brain and Lung Lesions

The American Cancer Society estimates 9,230 cases of breast cancer will be diagnosed in Illinois this year, some of which may also be facing the spread of the disease to other organs. Patients with metastatic breast cancer often require a secondary or adjuvant treatment option for tumors that have spread to other parts of the body, which are most commonly the brain or lung. In these cases, stereotactic radiosurgery using CyberKnife® can be prescribed in tandem with other breast cancer treatment methods like chemotherapy to reduce side effects and overall treatment time.

At Illinois CyberKnife, our experienced physician staff treats metastatic breast cancer using CyberKnife. This approach has a particular benefit for patients with multiple brain or lung lesions as the CyberKnife tracking system precisely focuses and delivers hundreds of radiation beams from different angles to the tumor, reducing radiation exposure to nearby healthy tissue and maximizing the dose delivered to cancer cells. The highly accurate targeting system also enables the CyberKnife to adjust for normal patient movement such as breathing while maintaining focus on targeted tumors.

CyberKnife treatment is an outpatient procedure that can be completed within five treatment sessions. Patients undergoing chemotherapy can also receive CyberKnife treatment concurrently and experience few to no side effects from the CyberKnife procedure.

For more information on how CyberKnife can be incorporated into your treatment plan, call our center.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.